Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis

被引:175
作者
Namekawa, T
Snyder, MR
Yen, JH
Goehring, BE
Leibson, PJ
Weyand, CM
Goronzy, JJ
机构
[1] Mayo Clin & Mayo Fdn, Dept Med Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
关键词
D O I
10.4049/jimmunol.165.2.1138
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expansion of CD4(+)CD28(null) T cells is a characteristic finding in patients with rheumatoid arthritis, Despite lacking CD28 molecules, these unusual CD4 T cells undergo clonal proliferation and form large and long-lived clonal populations, They produce high levels of IFN-gamma, exhibit autoreactivity, and have cytolytic function. The mechanisms facilitating the expansion and longevity of CD4(+)CD28(null) T cell clones in vivo are unknown. Here, we report that CD4(+)CD28(null), but not CD4(+)CD28(+), T cells express MHC class I-recognizing receptors normally found on NK cells. CD4(+)CD28(null) T cells preferentially expressed killer cell activating receptors (KAR), often in the absence of killer cell inhibitory receptors, Cross-linking of KAR molecules enhanced the proliferative response to TCR-mediated stimulation, but not the cytolytic function of CD4(+)CD28(null) T cells, suggesting different signaling pathways in CD4 T cells and NK cells. Triggering of KAR signaling led to the phosphorylation of several cellular targets, although the pattern of phosphorylation differed from that induced by the TCR, Aberrant expression of KAR molecules in the absence of inhibitory receptors and in the appropriate HLA setting may lead to the clonal outgrowth of autoreactive CD4(+)CD28(null) T cells commonly seen in rheumatoid arthritis.
引用
收藏
页码:1138 / 1145
页数:8
相关论文
共 45 条
  • [1] AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315
  • [2] Mouse CD1-specific NK1 T cells: Development, specificity, and function
    Bendelac, A
    Rivera, MN
    Park, SH
    Roark, JH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 535 - 562
  • [3] The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
    Biassoni, R
    Cantoni, C
    Falco, M
    Verdiani, S
    Bottino, C
    Vitale, M
    Conte, R
    Poggi, A
    Moretta, A
    Moretta, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 645 - 650
  • [4] Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
    Borrego, F
    Ulbrecht, M
    Weiss, EH
    Coligan, JE
    Brooks, AG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 813 - 818
  • [5] HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
    Braud, VM
    Allan, DSJ
    O'Callaghan, CA
    Söderström, K
    D'Andrea, A
    Ogg, GS
    Lazetic, S
    Young, NT
    Bell, JI
    Phillips, JH
    Lanier, LL
    McMichael, AJ
    [J]. NATURE, 1998, 391 (6669) : 795 - 799
  • [6] NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
    Brooks, AG
    Posch, PE
    Scorzelli, CJ
    Borrego, F
    Coligan, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) : 795 - 800
  • [7] Brumbaugh KM, 1996, J IMMUNOL, V157, P2804
  • [8] The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
    Carretero, M
    Cantoni, C
    Bellon, T
    Bottino, C
    Biassoni, R
    Rodriguez, A
    PerezVillar, JJ
    Moretta, L
    Moretta, A
    LopezBotet, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) : 563 - 567
  • [9] Chapman A, 1996, J IMMUNOL, V157, P4771
  • [10] CLONING OF IMMUNOGLOBULIN-SUPERFAMILY MEMBERS ASSOCIATED WITH HLA-C AND HLA-B RECOGNITION BY HUMAN NATURAL-KILLER-CELLS
    COLONNA, M
    SAMARIDIS, J
    [J]. SCIENCE, 1995, 268 (5209) : 405 - 408